In immune-competent BALB/c mice, the in vivo tumor growth of 4T1-CXCL13 was significantly inhibited and even completely eradicated, accompanied with increased infiltrations of CD4+, CD8+ T lymphocytes, and CD11b+CD11c+ DCs. This evidence concerns the gene CXCL13 and neoplasm.